Together they complement each other, but either is better than neither
(However, note that when injecting intramuscularly or subcutaneously, any trace preservative is generally well tolerated
See the full vetting rubric
On July 5, Novo Nordisk launched a phase III clinical trial of CagriSema injection in China, the purpose of which is to compare the safety and efficacy of CagriSema injection with semeglutide in obese and overweight patients in China
Thus were the conclusions made in a 2015 paper published in Cell Metabolism , in which the authors noted that MOTS-c has physiological similarities to the first-line diabetes drug metformin with regard to managing glucose utilization, metabolism, and body weight.18 Reduced body fat Considering the effects that MOTS-c has on insulin response and glucose uptake two factors associated with weight gain the authors of the 2015 paper referenced above also examined the peptides potential for preventing obesity.19 Specifically, in a group of mice fed a high-fat diet, MOTS-c appeared to prevent obesity onset.18 Other studies have corroborated these results by finding that higher plasma MOTS-c levels are negatively correlated with obesity.20 Improved physical performance Recall that endogenous MOTS-c can be activated by exercise, allowing your skeletal muscles to use glucose for energy to meet their high energy demand
